387 related articles for article (PubMed ID: 20736472)
1. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
[TBL] [Abstract][Full Text] [Related]
2. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
[TBL] [Abstract][Full Text] [Related]
3. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria.
Araki S; Haneda M; Sugimoto T; Isono M; Isshiki K; Kashiwagi A; Koya D
Diabetes Care; 2006 Apr; 29(4):864-8. PubMed ID: 16567829
[TBL] [Abstract][Full Text] [Related]
5. Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes--an 8-year prospective cohort analysis of 1297 patients.
Wang Y; Luk AO; Ma RC; So WY; Tam CH; Ng MC; Yang X; Baum L; Lam V; Tong PC; Chan JC
Diabet Med; 2010 Apr; 27(4):376-83. PubMed ID: 20536507
[TBL] [Abstract][Full Text] [Related]
6. [Association between mannose-binding lectin 2 gene and protein kinase C-beta 1 gene polymorphisms and type 2 diabetic macrovascular complications in northern Chinese Han population].
Zhang NN; Yao L; Zhuang MQ; Wang GC; Chen TT; Yang YJ; Zhang J; Lv M; Jin L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):709-14. PubMed ID: 23225056
[TBL] [Abstract][Full Text] [Related]
7. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
8. Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal Recipients.
Liu Y; Zhou J; Luo X; Yang C; Zhang Y; Shi S
PLoS One; 2016; 11(2):e0148270. PubMed ID: 26841219
[TBL] [Abstract][Full Text] [Related]
9. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.
Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A
Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344
[TBL] [Abstract][Full Text] [Related]
10. Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.
Araki S; Ng DP; Krolewski B; Wyrwicz L; Rogus JJ; Canani L; Makita Y; Haneda M; Warram JH; Krolewski AS
J Am Soc Nephrol; 2003 Aug; 14(8):2015-24. PubMed ID: 12874455
[TBL] [Abstract][Full Text] [Related]
11. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients.
Böger CA; Fischereder M; Deinzer M; Aslanidis C; Schmitz G; Stubanus M; Banas B; Krüger B; Riegger GA; Krämer BK
Atherosclerosis; 2005 Nov; 183(1):121-9. PubMed ID: 15899487
[TBL] [Abstract][Full Text] [Related]
12. Investigation of P213S SELL gene polymorphism in type 2 diabetes mellitus and related end stage renal disease. A case-control study.
Stavarachi M; Panduru NM; Serafinceanu C; Moţa E; Moţa M; Cimponeriu D; Ion DA
Rom J Morphol Embryol; 2011; 52(3 Suppl):995-8. PubMed ID: 22119815
[TBL] [Abstract][Full Text] [Related]
13. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
[TBL] [Abstract][Full Text] [Related]
14. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
[TBL] [Abstract][Full Text] [Related]
15. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
[TBL] [Abstract][Full Text] [Related]
16. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
17. Association of chemokine gene variants with end stage renal disease in North Indian population.
Singh V; Jaiswal PK; Tiwari P; Kapoor R; Mittal RD
Transpl Immunol; 2013 Jun; 28(4):189-92. PubMed ID: 23615182
[TBL] [Abstract][Full Text] [Related]
18. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease.
Vivante A; Afek A; Frenkel-Nir Y; Tzur D; Farfel A; Golan E; Chaiter Y; Shohat T; Skorecki K; Calderon-Margalit R
JAMA; 2011 Aug; 306(7):729-36. PubMed ID: 21846854
[TBL] [Abstract][Full Text] [Related]
19. The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥ 50 years.
Van Pottelbergh G; Bartholomeeusen S; Buntinx F; Degryse J
Nephrol Dial Transplant; 2012 Jun; 27(6):2297-303. PubMed ID: 22102615
[TBL] [Abstract][Full Text] [Related]
20. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.
Brancati FL; Whelton PK; Randall BL; Neaton JD; Stamler J; Klag MJ
JAMA; 1997 Dec; 278(23):2069-74. PubMed ID: 9403420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
